A5005788096- Platelet Disorders and Treatments
- Lymphoma Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Chronic Lymphocytic Leukemia Research
- Blood groups and transfusion
- Histone Deacetylase Inhibitors Research
- Global Cancer Incidence and Screening
- Blood properties and coagulation
- Multiple Myeloma Research and Treatments
- Economic and Financial Impacts of Cancer
- Acute Myeloid Leukemia Research
- T-cell and Retrovirus Studies
- Peptidase Inhibition and Analysis
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Diagnosis and Treatment
- Viral-associated cancers and disorders
- Dermatology and Skin Diseases
- Genetic factors in colorectal cancer
- Genomics and Rare Diseases
- Chronic Myeloid Leukemia Treatments
- CAR-T cell therapy research
- Nerve Injury and Rehabilitation
- Immune Cell Function and Interaction
- Colorectal Cancer Screening and Detection
Jacobi Medical Center
2018-2024
Albert Einstein College of Medicine
2020-2024
Montefiore Medical Center
2021-2024
BioLamina (Sweden)
2017-2024
Nanjing Medical University
2015-2024
Yeshiva University
2024
Chinese Academy of Medical Sciences & Peking Union Medical College
2017
Jiangsu Province Hospital
2015
Lung cancer as a second primary malignancy (lung-2) is increasingly common, but its prognosis poorly understood. This study aims to examine the overall and cancer-specific survival of patients diagnosed with lung-2 compared lung-1. Primary lung from 1988 2014 in Surveillance, Epidemiology, End Results (SEER) program were included. Lung-2 was identified previous diagnosis nonlung SEER. Hazard ratios (HRs) mortality estimated among lung-1, adjusting for age calendar period at diagnosis, sex,...
The pathophysiology of immune thrombocytopenia (ITP) involves immune-mediated platelet destruction. presence adipose tissue in obese individuals creates an inflammatory environment that could potentially impact the clinical course and outcomes ITP. However relationship between obesity ITP has not been well described. We evaluated 275 patients diagnosed with primary from 2012 to 2022. Patients were categorized into four groups based on their body mass index (BMI) at diagnosis. Female gender...
The pathophysiology of immune thrombocytopenia (ITP) involves immune-mediated platelet destruction. presence adipose tissue in obese individuals creates an inflammatory environment that could potentially impact the clinical course and outcomes ITP. However relationship between obesity ITP has not been well described. We evaluated 275 patients diagnosed with primary from 2012 to 2022. Patients were categorized into four groups based on their body mass index (BMI) at diagnosis. Female gender...
<title>Abstract</title> The pathophysiology of immune thrombocytopenia (ITP) involves immune-mediated platelet destruction. presence adipose tissue in obese individuals creates an inflammatory environment that could potentially impact the clinical course and outcomes ITP. However relationship between obesity ITP has not been well described. We evaluated 275 patients diagnosed with primary from 2012 to 2022. Patients were categorized into four groups based on their body mass index (BMI) at...
8538 Background: Lung cancer is the leading cause of cancer-related death in US. Non-elderly, early stage (stage I&II) non-small cell lung (NSCLC) patients have most promising prognosis with appropriate treatments. Studies shown uninsured and elderly on Medicaid being less likely to receive guideline-concordant therapy thus higher mortality. However, it remains unknown how insurance status influences cause-specific survival non-elderly NSCLC patients, whether disparity care improved this...
Brachial plexopathy, also known as Parsonage–Turner syndrome or neuralgic amyotrophy, is an uncommon peripheral neuropathy characterized by acute-onset, dull, severe pain followed limb weakness ...
e19550 Background: Patients with peripheral T-cell lymphoma (PTCL) lack good treatment options, particularly in the relapsed and refractory setting. Our work suggested that epigenetic therapies can be safe effective for patients PTCL, those lymphomas a follicular helper (TFH) phenotype. It is thought recurrent mutations factors, including Ten-Eleven Translocation-2 (TET2), DNA methyl transferase-3A (DNMT3A) isocitrate dehydrogenase-2 (IDH2) may contribute to PTLC vulnerability drugs....
e21005 Background: Cancer survivors are at increased risk of developing a second primary malignancy, including lung cancer. However, prognosis cancer as malignancy (lung-2) remains largely unknown. This study aims to investigate the lung-2 in relevant first (lung-1). Methods: Lung patients from 1988 2014 Surveillance, Epidemiology, and End Results program were included. Overall specific mortality main outcome. Second was defined according SEER rules. Results: 679,541 85,758 included lung-1...
e20566 Background: Lung cancer is the second most common and leading cause of cancer-related death in US. Of 222,500 newly diagnosed lung cases, 10-15% are SCLC. The average 5-year survival rate SCLC poor ranging from 2-31% based on stage. Among elderly patients, it has been showed that uninsured Medicaid were less likely to receive guideline-concordant therapy have higher overall mortality. We aim explore influence health insurance Affordable Care Act (ACA) treatment younger patients....
e21049 Background: Lung cancer is the leading cause of cancer-related death in US. In 2017 there were approximately 222,500 newly diagnosed lung cases with 80-85% being NSCLC. Thirty percent them was before 65 years old. Among elderly patients, studies demonstrated that uninsured and Medicaid patients less likely to receive guideline-concordant therapy have higher overall mortality. It remains unknown how insurance status influences treatment survival NSCLC than years. Methods: identified...